WELLPHARMA
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
WELLPHARMA - overview
Established
2018
Location
Tokyo, -, Japan
Primary Industry
Consumer Products
About
Based in Japan, and founded in 2018, WELLPHARMA, formerly known as Beauty Nutrition Co. , Ltd. , operates as an original equipment manufacturing (OEM) company. In May 2022, WELLPHARMA Inc.
raised JPY 150 million in Series A funding led by POLA OBIS HOLDINGS INC. and MTG Ventures. As of 2022, the company’s CEO is Issei Fukuda. WELLPHARMA manufactures a wide range of products such as CBD (cannabidiol) oil, supplements, gummies, hard capsules, soft drinks, pet oil, cosmetics, and more.
In addition, the company also conducts pharmaceutical research on ligands, which are molecules that firmly bind to particular bodily receptors. The company plans to use the funds raised in May 2022 to support product launch, commercialization, and development, and to strengthen corporate functions and recruitment.
Current Investors
POLA ORBIS HOLDINGS INC., MTG Ventures
Primary Industry
Consumer Products
Sub Industries
Non-Alcoholic Beverages, Beauty & Hygiene, Pharmaceutical Research & Development
Website
www.wellpharma.co.jp
Verticals
Cannabis/Medical Marijuana, Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
WELLPHARMA - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.